Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.

Clinical trial NCT00183924 · COMPLETED

Trial details

NCT number: NCT00183924
Sponsor: University of Southern California
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Adenocarcinoma

Start date: 2001-03-01
Primary completion: 2006-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.